Table 3:

Selective serotonin reuptake inhibitor use among community-dwelling Medicare beneficiaries aged ≥65 by fall status – Medicare Current Beneficiary Surveys, 2010 −2017.

	Fall outcome
	Did not report fall			Reported 1 or more falls			Reported 2 or more falls
Medication exposure	na	Weighted %b	95% CIc	na	Weighted %b	95% CIc	na	Weighted %b	95% CIc
Citalopram/escitalopram
Overall	277	63.7	60.3–67.0	170	36.3	33.0–39.7	102	21.4	19.1–23.9
Low TSDDd	129	66.6	61.3–71.5	68	33.4	28.5–38.7	42	20.4	16.6–24.9
Medium TSDDd	72	58.6	50.7–66.0	53	41.4	34.0–49.3	28	20.6	15.9–26.4
High TSDDd	76	64.6	58.2–70.5	49	35.4	29.5–41.8	32	23.7	18.6–29.8
Sertraline
Overall	172	60.6	55.7–65.4	112	39.4	34.6–44.3	66	22.3	18.7–26.3
Low TSDDd	75	66.3	59.4–72.6	47	33.7	27.4–40.7	33	23.3	18.4–29.0
Medium TSDDd	35	51.5	40.5–62.4	26	48.5	37.6–59.5	*	*	*
High TSDDd	62	59.7	51.6–67.3	39	40.3	32.7–48.4	20	20.2	14.1–28.0

^{* =}Data not available due to small sample size

^an = unweighted number

^b% = weighted percent to the US Medicare population of characteristic

^cCI = 95% confidence interval

^dTSDD = Average monthly total standardized daily dose categorized into low (60 or less), medium (60.1–90), and high (more than 90). For citalopram: Low TSDD is equivalent to ≤20 mg daily for 30 days; Medium TSDD is equivalent to >20 mg to 30 mg daily for 30 days; High TSDD is equivalent to >30 mg daily for 30 days. For escitalopram: Low TSDD is equivalent to ≤10 mg daily for 30 days; Medium TSDD is equivalent to >10 mg to 15 mg daily for 30 days; High TSDD is equivalent to >15 mg daily for 30 days. For Sertraline: Low TSDD is equivalent to ≤50 mg daily for 30 days; Medium TSDD is equivalent to >50 mg to 75 mg daily for 30 days; High TSDD is equivalent to >75 mg daily for 30 days.